title: Management of parkinsonism and psychotic depression in a case of acute intermittent porphyria.
authors.forename: P F
authors.initials: PF
authors.lastname: Chinnery
authors.forename: N E
authors.initials: NE
authors.lastname: Cartlidge
authors.forename: D J
authors.initials: DJ
authors.lastname: Burn
authors.forename: P G
authors.initials: PG
authors.lastname: Cleland
authors.forename: I
authors.initials: I
authors.lastname: McKeith
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000150:complications* / Q000523:psychology / Q000628:therapy; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000150:complications* / Q000188:drug therapy*; D010479:Pergolide / Q000008:administration & dosage / Q000627:therapeutic use*; D017118:Porphyria, Acute Intermittent / Q000150:complications* / Q000188:drug therapy*; D011618:Psychotic Disorders / Q000150:complications* / Q000523:psychology / Q000628:therapy
chemical_list: D000978:Antiparkinson Agents; D010479:Pergolide